We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genes Identified That Increase Children's Risk Of Blood Infection

By LabMedica International staff writers
Posted on 16 Jun 2016
Print article
Image: The MassARRAY system for iPlex single nucleotide polymorphism (SNP) genotyping (Photo courtesy of Sequenom).
Image: The MassARRAY system for iPlex single nucleotide polymorphism (SNP) genotyping (Photo courtesy of Sequenom).
Bacteremia is a bacterial infection of the bloodstream, and a major cause of illness and death in sub-Saharan Africa but little is known about whether human genetics play a part.

The leading bacterial cause of death in young children worldwide is Streptococcus pneumoniae or pneumococcus and 14.5 million episodes of serious pneumococcal disease occur in young children annually. Genes have been identified that make certain children more susceptible to invasive bacterial infections.

A global network of scientists coordinated from the Wellcome Trust Centre for Human Genetics (Oxford, UK), carried out a genome-wide association study to identify which genes might be associated with an increased likelihood of developing bacteremia. The study looked at DNA samples from more than 4,500 Kenyan children from the Kilifi area where there is a high occurrence of bacteremia. Just over 4,000 children were healthy, while slightly more than 500 had pneumococcal bacteremia.

Genomic DNA was extracted using the QIAamp DNA blood mini kit (QIAGEN, Hilden, Germany) and whole-genome amplified samples from case and control subjects were genotyped on the genome-wide Affymetrix SNP 6.0 chip (Affymetrix Inc, Santa Clara, CA, USA). Single nucleotide polymorphisms (SNP) in the additive or the genotypic model were directly genotyped in the discovery set to confirm imputation accuracy and in the replication sample set to confirm the associations using two iPLEX assays (Sequenom, San Diego, CA, USA). To quantify levels of long intergenic non-coding ribonucleic acid (RNA) expression, the teams performed quantitative real-time polymerase chain reaction (qPCR) using a relative quantification method.

The study found an area of two long intergenic noncoding RNA (lincRNA) genes that was associated with susceptibility to pneumococcal bacteremia. LincRNAs are RNA transcripts that are longer than 200 nucleotides but are not translated into proteins. LincRNAs are still little understood, although it is believed that the human genome has more than 10,000 of them.

Anna Rautanen, PhD, a senior author of the study, said, “'One of the associated lincRNA genes, called AC011288.2, is expressed only in neutrophils, cells that are known to have a key role in clearing pneumococcal disease. Critically, the genetic variants we have identified carry a doubled risk of developing bacteremia when infected with the Streptococcus pneumoniae bacteria. This discovery therefore provides clues in the pressing search for new ways to target the disease.” The study was published on June 2, 2016, in the American Journal of Human Genetics.

Related Links:
Wellcome Trust Centre for Human Genetics
QIAGEN
Affymetrix
Sequenom
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more